Ranbaxy Laboratories trades higher on the bourses

12 Mar 2014 Evaluate

Ranbaxy Laboratories is currently trading at Rs. 366.65, up by 2.10 points or 0.58% from its previous closing of Rs. 364.55 on the BSE.

The scrip opened at Rs. 366.00 and has touched a high and low of Rs. 368.35 and Rs. 363.00 respectively. So far 77061 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 490.15 on 06-Jan-2014 and a 52 week low of Rs. 253.95 on 02-Aug-2013.

Last one week high and low of the scrip stood at Rs. 375.00 and Rs. 356.00 respectively. The current market cap of the company is Rs. 15537.86 crore.

The promoters holding in the company stood at 63.41% while Institutions and Non-Institutions held 19.55% and 15.38% respectively.

Ranbaxy Laboratories is reportedly in talks with at least two companies on sourcing ingredients for a generic version of AstraZeneca Plc’s heartburn drug Nexium, after a US ban on shipments from a plant in India. Nexium had global sales last year of $3.87 billion.

Earlier in January, Washington prohibited Ranbaxy, from selling drugs in the United States using ingredients from one of its plants in northern India due to poor manufacturing practices.

Ranbaxy Laboratories is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies.

Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×